Stock & Company Details
Charles River Laboratories International Inc. $CRL
Price:
N/A
N/A
48M
$14B
52 Week High:
N/A
10 Day Average Volume:
N/A
-61.42
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Commercial Services
CRL technical indicators
Latest Charles River Laboratories International Inc. (CRL) indicator readings as of 2026-10-09.
CRL's 14-day RSI is 58.9, in neutral territory. At $301.79 it is trading 41.9% above its 200-day moving average of $212.62, and above its 50-day average of $283.17. Price sits in the middle of its Bollinger Bands ($267.20 to $311.43). ADX reads 31.8, indicating a trending market.
CRL backtested strategy results
How 4 rule-based strategies performed on Charles River Laboratories International Inc. (CRL) over recent history, last backtested 2026-10-09. Select a strategy to plot its trades on the chart above. Past performance does not predict future results.
| Strategy | Equity curve | Return | Win rate | Trades | Max drawdown |
|---|---|---|---|---|---|
| Oversold Bounce Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | +5.4% | 33% | 12 | -48.2% | |
| Momentum Crossover Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | +5.4% | 32% | 25 | -58.8% | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | -0.0% | 46% | 26 | -45.1% | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | +44.8% | 65% | 26 | -35.3% |
Overview
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.
Finance Bot
Ask your questions
Start by typing a question below.
